Home > Browse > Science > Insilico Medicine

Insilico Medicine

Insilico Medicine is an AI-powered Science tool — End-to-end AI platform for drug development and aging research. Best for: Data Analysis & Data Visualization. Pricing: Paid (GateOnAI Score: 52/100).

End-to-end AI platform for drug development and aging research.

PaidVerifiedData AnalysisData VisualizationPredictive AnalyticsAI AssistantAI AgentLarge Language ModelComputer VisionNatural Language ProcessingMachine LearningDeep Learning

Provides a full AI workflow for drug discovery and aging studies, linking data ingestion, target validation, and candidate design in a single cloud environment. The platform ingests genomics, proteomics, and clinical datasets, then applies deep learning to rank disease targets and predict protein‑ligand interactions. A generative chemistry module creates novel molecular structures that satisfy ADMET constraints, while an aging‑research suite models senescence pathways and suggests geroprotective interventions. Users can run virtual clinical trial simulations that estimate efficacy and safety across patient sub‑populations, and the system outputs detailed reports for regulatory review.\nThe tool includes an automated biomarker discovery engine that extracts predictive signatures from multi‑omics data, a reinforcement‑learning based synthesis planner that reduces experimental cycles, and a cloud‑native notebook interface for custom model tweaking. Integration points cover common bioinformatics pipelines such as KNIME, Galaxy, and Jupyter, allowing seamless data flow. Comparative benchmarking shows its target‑prediction accuracy aligns with leading academic models, and its generative models produce chemically diverse hits that pass Lipinski filters without manual curation. Insilico’s aging module uniquely combines epigenetic clocks with intervention scoring, a feature rarely found in competing platforms.\nPricing is limited to a paid subscription, with tiered access based on compute credits and data storage. Primary users are pharmaceutical R&D teams, biotech startups, and academic labs focused on translational aging research. The subscription includes regular model updates, technical support, and compliance documentation, making it a practical choice for organizations that need end‑to‑end AI support without building in‑house infrastructure.

Visit Insilico Medicine

More Science Tools

Works Well With

Tools that Insilico Medicine genuinely connects with, based on real input/output compatibility data (not just shared category):

Find similar tools | Browse all AI prompts